Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 1
1987 1
1988 2
1989 1
1991 1
1992 1
1993 2
1994 2
1995 1
1996 1
1997 4
1998 2
1999 3
2000 2
2001 2
2002 1
2003 1
2004 2
2005 5
2006 2
2007 7
2008 1
2009 3
2010 2
2011 6
2012 5
2013 5
2014 5
2015 3
2016 1
2017 4
2018 1
2019 2
2020 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J; PROactive Investigators. Dormandy JA, et al. Among authors: betteridge j. Lancet. 2005 Oct 8;366(9493):1279-89. doi: 10.1016/S0140-6736(05)67528-9. Lancet. 2005. PMID: 16214598 Free article. Clinical Trial.
IBD HINTS for Preventive Care.
Hall N, Betteridge JD, Singla MB. Hall N, et al. Among authors: betteridge jd. Inflamm Bowel Dis. 2017 Sep;23(9):E42. doi: 10.1097/MIB.0000000000001177. Inflamm Bowel Dis. 2017. PMID: 28816758 No abstract available.
Residual macrovascular risk in 2013: what have we learned?
Fruchart JC, Davignon J, Hermans MP, Al-Rubeaan K, Amarenco P, Assmann G, Barter P, Betteridge J, Bruckert E, Cuevas A, Farnier M, Ferrannini E, Fioretto P, Genest J, Ginsberg HN, Gotto AM Jr, Hu D, Kadowaki T, Kodama T, Krempf M, Matsuzawa Y, Núñez-Cortés JM, Monfil CC, Ogawa H, Plutzky J, Rader DJ, Sadikot S, Santos RD, Shlyakhto E, Sritara P, Sy R, Tall A, Tan CE, Tokgözoğlu L, Toth PP, Valensi P, Wanner C, Zambon A, Zhu J, Zimmet P; Residual Risk Reduction Initiative (R3i). Fruchart JC, et al. Among authors: betteridge j. Cardiovasc Diabetol. 2014 Jan 24;13:26. doi: 10.1186/1475-2840-13-26. Cardiovasc Diabetol. 2014. PMID: 24460800 Free PMC article. Review.
Probiotics for the treatment of inflammatory bowel disease.
Veerappan GR, Betteridge J, Young PE. Veerappan GR, et al. Among authors: betteridge j. Curr Gastroenterol Rep. 2012 Aug;14(4):324-33. doi: 10.1007/s11894-012-0265-5. Curr Gastroenterol Rep. 2012. PMID: 22581276 Review.
Pitavastatin - results from phase III & IV.
Betteridge J. Betteridge J. Atheroscler Suppl. 2010 Dec;11(3):8-14. doi: 10.1016/S1567-5688(10)71064-3. Atheroscler Suppl. 2010. PMID: 21193153 Review.
Olive oil and the Mediterranean diet: implications for health in Europe.
Assmann G, de Backer G, Bagnara S, Betteridge J, Crepaldi G, Fernandez-Cruz A, Godtfredsen J, Jacotot B, Paoletti R, Renaud S, Ricci G, Rocha E, Trautwein E, Urbinati GC, Varela G, Williams C. Assmann G, et al. Among authors: betteridge j. Br J Nurs. 1997 Jun 26-Jul 9;6(12):675-7. doi: 10.12968/bjon.1997.6.12.675. Br J Nurs. 1997. PMID: 9238914 Review. No abstract available.
International consensus statement on olive oil and the Mediterranean diet: implications for health in Europe. The Olive Oil and the Mediterranean Diet Panel.
Assmann G, de Backer G, Bagnara S, Betteridge J, Crepaldi G, Fernandez-Cruz A, Godtfredsen J, Jacotot B, Paoletti R, Renaud S, Ricci G, Rocha E, Trautwein E, Urbinati GC, Varela G, Williams C. Assmann G, et al. Among authors: betteridge j. Eur J Cancer Prev. 1997 Oct;6(5):418-21. doi: 10.1097/00008469-199710000-00002. Eur J Cancer Prev. 1997. PMID: 9466113 Review. No abstract available.
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.
Lincoff AM, Nicholls SJ, Riesmeyer JS, Barter PJ, Brewer HB, Fox KAA, Gibson CM, Granger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Wolski K, Ruotolo G, Vangerow B, Weerakkody G, Goodman SG, Conde D, McGuire DK, Nicolau JC, Leiva-Pons JL, Pesant Y, Li W, Kandath D, Kouz S, Tahirkheli N, Mason D, Nissen SE; ACCELERATE Investigators. Lincoff AM, et al. N Engl J Med. 2017 May 18;376(20):1933-1942. doi: 10.1056/NEJMoa1609581. N Engl J Med. 2017. PMID: 28514624 Free article. Clinical Trial.
81 results